1. Influence of the multidrug transporter P-glycoprotein on the intracellular pharmacokinetics of vandetanib

   • C. Jovelet
   • A. Deroussent
   • S. Gil

   Original Paper 28 February 2013 Pages: 149 - 157

   

2. Effect of borneol on cytochrome P450 3A enzyme and midazolam pharmacokinetics in rats

   • Rong Zhang
   • Sui-Qing Mi
   • Ning-Sheng Wang

   Original Paper 16 April 2013 Pages: 159 - 169

   

3. Pharmacokinetics of 5-fluorouracil and increased hepatic dihydropyrimidine dehydrogenase activity levels in 1,2-dimethylhydrazine-induced colorectal cancer model rats

   • Shinji Kobuchi
   • Yukako Ito
   • Kanji Takada

   Original Paper 30 November 2012 Pages: 171 - 181

   

4. In vivo distribution of 5-Fluorouracil after peritumoral implantation using a biodegradable micro-device in tumor-bearing mice

   • Na Zheng
   • Mingyao Zhou
   • Wen Lu

   Original Paper 22 November 2012 Pages: 183 - 190

   

5. Convolution and validation of in vitro–in vivo correlation of water-insoluble sustained-release drug (domperidone) by first-order pharmacokinetic one-compartmental model fitting equation

   • Anirbandeep Bose
   • Wong Tin Wui

   Original Paper 23 December 2012 Pages: 191 - 200

   

6. Determination of phillygenin in rat plasma by high-performance liquid chromatography and its application to pharmacokinetic studies

   • Liang-hong Ye
   • Yun-xia Li
   • Xin-guang Zheng

   Original Paper 07 April 2013 Pages: 201 - 207

   

7. Pharmacokinetics of lansoprazole and its main metabolites after single and multiple intravenous doses in healthy Chinese subjects

   • Dan Zhang
   • Yanan Zhang
   • Huichen Liu

   Short Communication 11 December 2012 Pages: 209 - 215

   

8. Genotype and allele frequencies of polymorphic UGT1A9 in the Polish population

   • Oliwia Zakerska
   • Marzena Skrzypczak-Zielinska
   • Ryszard Slomski

   Short Communication 25 November 2012 Pages: 217 - 221